Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
Formato:	Artigo
Idioma:	Inglês
Publicado em:	SpringerOpen 2024-11-01
coleção:	Future Journal of Pharmaceutical Sciences
Assuntos:	Metformin hydrochloride Teneligliptin hydrobromide hydrate Pioglitazone hydrochloride Analytical quality by design Response surface modeling
Acesso em linha:	https://doi.org/10.1186/s43094-024-00746-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!